Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MP | 0.01% | $5.15B | +129.18% | 0.00% |
DCO | -0.01% | $1.23B | +42.03% | 0.00% |
TS | -0.03% | $18.14B | +19.99% | 4.38% |
LFUS | -0.04% | $5.71B | -7.97% | 1.21% |
IIIV | 0.05% | $678.14M | +23.82% | 0.00% |
POAI | 0.05% | $7.43M | -18.43% | 0.00% |
LINC | 0.06% | $734.22M | +93.99% | 0.00% |
APPN | 0.07% | $2.26B | -2.15% | 0.00% |
GFI | 0.08% | $21.24B | +58.84% | 2.32% |
KSS | 0.09% | $1.03B | -56.95% | 13.80% |
IRMD | -0.09% | $769.39M | +38.56% | 1.06% |
EXK | -0.09% | $1.46B | +41.85% | 0.00% |
COCO | -0.09% | $2.09B | +31.42% | 0.00% |
NVGS | 0.10% | $989.06M | -20.27% | 1.40% |
YALA | -0.11% | $896.02M | +49.33% | 0.00% |
CGNT | 0.12% | $679.27M | +20.87% | 0.00% |
HGV | 0.12% | $3.95B | +9.83% | 0.00% |
NIU | -0.12% | $238.35M | +93.22% | 0.00% |
EPAM | 0.13% | $10.14B | -2.32% | 0.00% |
PTON | 0.13% | $2.63B | +94.69% | 0.00% |
Double maintains 14 strategies that include JNJ - Johnson & Johnson
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TLN | -34.66% | $12.74B | +137.28% | 0.00% |
VRT | -34.10% | $46.70B | +39.25% | 0.11% |
ANET | -32.43% | $124.22B | +10.82% | 0.00% |
NVDA | -32.38% | $3.74T | +24.97% | 0.03% |
STRL | -30.73% | $6.77B | +97.01% | 0.00% |
VST | -30.05% | $62.81B | +111.06% | 0.48% |
CRDO | -29.94% | $14.87B | +179.39% | 0.00% |
CLS | -29.39% | $17.12B | +153.81% | 0.00% |
EME | -29.25% | $23.76B | +48.76% | 0.19% |
MOD | -28.00% | $5.13B | -6.99% | 0.00% |
ETN | -27.80% | $138.93B | +13.33% | 1.12% |
GEV | -27.77% | $138.11B | +197.98% | 0.05% |
FIX | -27.24% | $18.40B | +77.52% | 0.29% |
CAMT | -27.01% | $3.74B | -35.57% | 0.00% |
LITE | -26.81% | $6.35B | +69.61% | 0.00% |
AVGO | -26.59% | $1.25T | +59.72% | 0.87% |
PWR | -26.27% | $55.17B | +50.25% | 0.13% |
IESC | -25.97% | $5.74B | +113.30% | 0.00% |
POWL | -25.64% | $2.53B | +45.12% | 0.51% |
ALAB | -25.61% | $14.62B | +46.55% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JEMA | 0.03% | $1.22B | 0.34% |
SCHK | 0.04% | $4.29B | 0.03% |
SCHX | 0.05% | $55.66B | 0.03% |
ESGU | 0.07% | $13.71B | 0.15% |
PPI | -0.07% | $56.02M | 0.78% |
VOTE | 0.08% | $812.10M | 0.05% |
XT | 0.08% | $3.39B | 0.46% |
SILJ | 0.08% | $1.38B | 0.69% |
DXJ | -0.09% | $3.51B | 0.48% |
GSUS | -0.09% | $2.60B | 0.07% |
BATT | -0.11% | $61.71M | 0.59% |
LCTU | 0.14% | $1.27B | 0.14% |
IYY | -0.15% | $2.47B | 0.2% |
HYZD | -0.15% | $174.02M | 0.43% |
BBUS | 0.17% | $5.01B | 0.02% |
QDPL | 0.18% | $1.02B | 0.6% |
JPEF | -0.18% | $1.55B | 0.5% |
EWY | -0.20% | $4.85B | 0.59% |
VXF | -0.20% | $22.28B | 0.05% |
EMXC | -0.23% | $13.62B | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHE | 60.57% | $550.10M | 0.39% |
IYK | 59.94% | $1.45B | 0.4% |
PPH | 59.15% | $612.06M | 0.36% |
HDV | 56.92% | $10.98B | 0.08% |
LVHD | 56.82% | $558.77M | 0.27% |
XLV | 54.83% | $34.14B | 0.09% |
XLP | 54.17% | $15.86B | 0.09% |
KXI | 53.66% | $851.26M | 0.41% |
IXJ | 53.53% | $3.73B | 0.41% |
SPHD | 53.02% | $3.14B | 0.3% |
FTXG | 52.96% | $28.63M | 0.6% |
IYH | 52.16% | $2.71B | 0.39% |
SPLV | 52.11% | $7.62B | 0.25% |
FHLC | 51.16% | $2.43B | 0.084% |
VHT | 50.91% | $15.27B | 0.09% |
FDL | 50.76% | $5.40B | 0.43% |
DHS | 50.27% | $1.22B | 0.38% |
FSTA | 50.25% | $1.35B | 0.084% |
VDC | 49.57% | $7.59B | 0.09% |
SDY | 47.69% | $19.86B | 0.35% |
Yahoo
MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.
SeekingAlpha
Verizon Communications Inc. stands out as the top Dow dividend pick with strong cash flow and value potential. Click for my analysis and why I like VZ.
Yahoo
JNJ is banking on Darzalex, Tremfya and new drugs to offset Stelara's LOE and Part D headwinds in Q2 Innovative Medicine sales.
Finnhub
Regeneron Pharmaceuticalssaid on Wednesday the U.S. Food and Drug Administration hasapproved its drug for a type of blood cancer called multiplemyeloma that has recurred in patients who had...
Finnhub
Insulin-producing human pancreascells can be manufactured with 3D printers, researchers reportedat the International Transplant Congress underway in London. Using a bio-ink made from...
SeekingAlpha
For the quarter, Thrivent Mid Cap Value Fund underperformed its benchmark due to negative stock selection.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QFLR | -24.40% | $298.78M | 0.89% |
SMH | -22.51% | $26.31B | 0.35% |
FFOG | -22.24% | $148.53M | 0.55% |
WTAI | -21.44% | $209.29M | 0.45% |
MAGS | -21.43% | $2.48B | 0.29% |
PSI | -21.35% | $724.18M | 0.56% |
CLSE | -20.86% | $189.59M | 1.44% |
YMAG | -20.61% | $352.42M | 1.12% |
IYW | -20.34% | $21.25B | 0.39% |
IGPT | -20.20% | $480.91M | 0.58% |
IGM | -20.10% | $6.60B | 0.41% |
AIPI | -19.92% | $322.35M | 0.65% |
ARTY | -19.79% | $1.08B | 0.47% |
FBCG | -19.60% | $4.37B | 0.59% |
SOXQ | -19.48% | $488.04M | 0.19% |
FBY | -19.39% | $176.46M | 1.06% |
VGT | -18.96% | $93.22B | 0.09% |
FTEC | -18.93% | $13.83B | 0.084% |
SIXG | -18.87% | $622.23M | 0.3% |
XLK | -18.43% | $79.00B | 0.09% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ED | 56.49% | $36.31B | +13.27% | 3.35% |
NVS | 56.17% | $233.59B | +15.65% | 3.24% |
DUK | 53.57% | $92.39B | +19.10% | 3.55% |
KO | 53.29% | $308.49B | +13.49% | 2.78% |
SO | 53.13% | $101.44B | +19.02% | 3.16% |
EXC | 52.90% | $43.82B | +25.72% | 3.63% |
AWK | 52.82% | $27.80B | +10.98% | 2.21% |
CMS | 52.57% | $20.98B | +18.92% | 3.04% |
ABT | 52.37% | $237.07B | +32.03% | 1.68% |
ES | 52.29% | $23.71B | +14.21% | 4.57% |
WEC | 52.15% | $33.43B | +34.23% | 3.33% |
PNW | 52.09% | $10.85B | +19.48% | 3.95% |
GSK | 52.01% | $78.84B | +1.94% | 4.17% |
O | 51.92% | $52.20B | +10.24% | 5.99% |
AEP | 51.67% | $55.76B | +19.14% | 3.55% |
POR | 51.47% | $4.48B | -3.74% | 4.98% |
PFE | 51.31% | $142.36B | -10.03% | 6.76% |
WTRG | 51.13% | $10.56B | +1.65% | 3.49% |
CPB | 50.39% | $9.45B | -30.40% | 4.79% |
DTE | 50.22% | $27.48B | +21.05% | 3.27% |
Current Value
$156.001 Year Return
Current Value
$156.001 Year Return